Determining the source of nosocomial transmission in hemodialysis units in Tunisia by sequencing NS5B and E2 sequences of HCV

Journal of Medical Virology

Volumn 79, Issue 8, 2007, Pages 1089-1094

  Hmaïed, Fatma ^a   Mamou, Myriam Ben ^a   Dubois, Martine ^b   Pasquier, Christophe ^b   Sandres Saune, Karine ^b   Rostaing, Lionel ^c   Slim, Amine ^a   Arrouji, Zakia ^a   Redjeb, Saida Ben ^a   Izopet, Jacques ^b  

^a CHARLES NICOLLE HOSPITAL   (Tunisia)

^b TOULOUSE UNIVERSITY HOSPITAL   (France)

^c CHU RANGUEIL   (France)

Author keywords

E2 region; Hemodialysis; Hepatitis C; Nosocomial transmission; NS5b region; Tunisia

Indexed keywords

ANTIBODY SCREENING; ARTICLE; E2 GENE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE SEQUENCE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HOSPITAL INFECTION; HUMAN; MOLECULAR PHYLOGENY; NONHUMAN; NS5B GENE; NUCLEOTIDE SEQUENCE; PHYLOGENY; PROSPECTIVE STUDY; QUANTITATIVE ASSAY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR; SEQUENCE ANALYSIS; SERUM; TUNISIA; VIRUS GENE; VIRUS STRAIN; VIRUS TRANSMISSION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CROSS INFECTION; FEMALE; HEMODIALYSIS UNITS, HOSPITAL; HEPACIVIRUS; HEPATITIS C; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PHYLOGENY; TUNISIA; VIRAL ENVELOPE PROTEINS; VIRAL NONSTRUCTURAL PROTEINS;

HEPATITIS C VIRUS;

EID: 34347332248     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.20877     Document Type: Article

References (28)

1. Ben Othman S, Bouzgarrou N, Achour A, Bourlet T, Pozzetto B, Trabelsi A. 2004a. High prevalence and incidence of hepatitis C virus infections among dialysis patients in the East-Centre of Tunisia. Pathol Biol 52:323-327.
2. Ben Othman S, Trabelsi A, Monnet A, Bouzgarrou N, Grattard F, Beyou A, Bourlet T, Pozzetto B. 2004b. Evaluation of a prototype HCV NS5b assay for typing strains of hepatitis C virus isolated from Tunisian haemodialysis patients. J Virol Methods 119:177-181.
3. Boyer N, Marcellin P. 2000. Pathogenesis, diagnosis management of hepatitis C. J Hepatol 32:98-112.
4. Bracho MA, Gosalbes MJ, Blasco D, Moya A, Gonzalez-Candelas F. 2005. Molecular epidemiology of a hepatitis C virus outbreak in a hemodialysis unit. J Clin Microbiol 43:2750-2755.
5. Cantaloube JF, Laperche S, Gallian P, Bouchardeau F, De Lamballerie X, de Micoo P. 2006. Analysis of the 5′ noncoding region versus the NS5b region in genotyping hepatitis C virus isolates from blood donors in France. J Clin Microbiol 44:2051-2056.
6. Furusyo N, Kubo N, Nakashima H, Kashiwagi K, Etoh Y, Hayashi J. 2004. Confirmation of nosocomial hepatitis C virus infection in a hemodialysis unit. Infect Control Hosp Epidemiol 25:584-590.
7. Halfon P, Roubicek C, Gerolami V, Quentin Y, Khiri H, Pepe G, Berland Y. 2002. Use of phylogenetic analysis of hepatitis C virus (HCV) hypervariable region 1 sequences to trace an outbreak of HCV in an autodialysis unit. J Clin Microbiol 40:1541-1545.
8. Hmaied F, Ben Mamou M, Saune-Sandres K, Rostaing L, Slim A, Arrouji Z, Ben Redjeb S, Izopet J. 2006. Hepatitis C virus infection among dialysis patients in Tunisia: Prevalence and molecular evidence for nosocomial transmission. J Med Virol 78: 185-191.
9. Hnatyszyn HJ. 2005. Chronic hepatitis C and genotyping: The clinical significance of determining HCV genotypes. Antivir Ther 10:1-11.
10. Izopet J, Pasquier C, Sandres K, Puel J, Rostaing L. 1999. Molecular evidence for nosocomial transmission of hepatitis C virus in a French hemodialysis unit. J Med Virol 58:139-144.
11. Izopet J, Sandres-Saune K, Kamar N, Salama G, Dubois M, Pasquier C, Rostaing L. 2005. Incidence of HCV infection in French hemodialysis units: A prospective study. J Med Virol 77: 70-76.
12. Jadoul M, Cornu C, VanYpersele de Strihou C. 1993. Incidence and risk factors for hepatitis C seroconversion in hemodialysis: A prospective study. Kidney Int 44:1322-1326.
13. Kumar S, Tamura K, Jakobson IB, Nei M. 2001. MEGA2: Molecular evolutionary genetics analysis software. Bioinformatics 17:1244-1245.
14. Laperche S, Saune K, Deny P, Duverlie G, Alain S, ChaixML, Gaudy K, Lunel F, Pawlotsky JM, Payan C, Pozzetto B, Tamalet C, Thibault V, Vallet S, Bouchardeau F, Izopet J, Lefrere JJ. 2006. Unique NS5B hepatitis C virus gene sequence consensus database is essential for standardization of genotype determination in multicenter epidemiological studies. J Clin Microbiol 44:614-616.
15. Le Pogam S, Le Chapois D, Christen R, Dubois F, Barin F, Goudeau A. 1998. Hepatitis C in a hemodialysis unit: Molecular evidence for nosocomial transmission. J Clin Microbiol 36:3040-3043.
16. Mizuno M, Higuchi T, Kanmatsuse K, Esumi M. 1998. Genetic and serological evidence for multiple instances of unrecognized transmission of hepatitis C virus in hemodialysis units. J Clin Microbiol 36:2926-2931.
17. Norder H, Bergtröm A, Uhnoo I, Aldén J, Weiss L, Czajkowski J, Magnius L. 1998. Confirmation of nosocomial transmission of hepatitis C virus by phylogenetic analysis of the NS5-B region. J Clin Microbiol 36:3066-3069.
18. Parker SR. 1997. Sequence navigator. Multiple sequence alignment software. Methods Mol Biol 70:145-154.
19. Robertson B, Myers G, Howard C, Brettin T, Bukh J, Gaschen B, Gojobori T, Maertens G, Mizokami M, Nainan O, Netesov S, Nishioka K, Shin T, Simmonds P, Smith D, Stuyver L, Weiner A. 1998. Classification, nomenclature, and database development for hepatitis C virus (HCV) and related viruses: Proposals for standardization. Arch Virol 12:2493-2503.
20. Rostaing L, Izopet J, Modesto-Segonds A. 1998. Hépatite C après greffe rénale. Presse Médicale 27:684-688.
21. Sandres-Sauné K, Deny P, Pasquier C, Thibaut V, Duverlie G, Izopet J. 2003. Determining hepatitis C genotype by analyzing the sequence of the NS5b region. J Virol Methods 109:187-193.
22. SaveyA, Simon F, Izopet J, Lepoutre A, Fabry J, Desenclos JC. 2005. A large nosocomial outbreak of hepatitis C virus infections at a hemodialysis center. Infect Contr Hosp Epidemiol 26:752-760.
23. Schroter M, Feucht HH, Zöllner B, Schäfer P, Laufs R. 2003. Multiple infections with different HCV genotypes: Prevalence and clinical impact. J Clin Virol 27:200-204.
24. Simmonds P, Bukh J, Combet C, Deleage G, Enomoto N, Feinstone S, Halfon P, Inchauspe G, Kuiken C, Maertens G, Mizokami M, Murphy DG, Okamoto H, Pawlotsky JM, Penin F, Sablon E, Shin-I T, Stuyver LJ, Thiel HJ, Viazov S, Weiner AJ, Widell A. 2005. Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology 42:962-973.
25. Stuyver L, Claeys H, Wyseur A, Van Arnhem W, De Beenhouwer H, Uytendaele S, Beckers J, Matthijs D, Leroux-Roels G, Maertens G, De Paepe M. 1996. Hepatitis C virus in a hemodialysis unit: Molecular evidence for nosocomial transmission. Kidney Int 49: 889-895.
26. Taskapan H, Oymak O, Dogukan A, Utas C. 2001. Patient to patient transmission of hepatitis C virus in hemodialysis units. Clin Nephrol 55:477-481.
27. Thompson JD, Higgins DG, Gibson TJ. 1994. CLUSTAL W: Improving the sensitivity of progressive multisequence alignement through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 22:4673-4680.
28. Zeuzem S, Hultcrantz R, Bourliere M, Goeser T, Marcellin P, Sanchez-Tapias J, Sarrazin C, Harvey J, Brass C, Albrecht J. 2004. Peginterferon alfa-2b plus ribavirin for treatment of chronic hepatitis C in previously untreated patients infected with HCV genotypes 2 or 3. J Hepatol 40:993-999.